Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant. The European Commission has ...
The Nature Portfolio journals will issue corrections, retraction statements and other post-publication updates including Editor’s Notes and Editorial Expressions of Concern on published content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback